[EN] HETEROCYCLIC COMPOUNDS AS ANTI-VIRAL AGENTS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES EN TANT QU'AGENTS ANTIVIRAUX
申请人:ENANTA PHARM INC
公开号:WO2021150806A1
公开(公告)日:2021-07-29
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV) or HMPV. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV or HMPV infection. The invention also relates to methods of treating an RSV or HMPV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
本发明公开了公式(I)的化合物,或其药用可接受的盐、酯或前药:其抑制呼吸道合胞病毒(RSV)或HMPV。本发明进一步涉及包含前述化合物的药物组合物,用于给药于患有RSV或HMPV感染的主体。该发明还涉及通过施用包含本发明化合物的药物组合物来治疗主体中的RSV或HMPV感染的方法。